The landscape of tools the World Health Organization (WHO) recommends for the diagnosis, treatment, care and support of people with drug-resistant TB continues to evolve. To help advocates stay up to date, Treatment Action Group (TAG) organized a series of virtual trainings for community and civil society organizations.

On Thursday, July 25th, TAG hosted a training on the basics of drug-resistant TB and the BPaL/M regimen. Drug-Resistant TB Basics covered how drug-resistant TB is defined, how it develops, and how it is treated. The training provided a close look at the BPaL/M regimen and an overview of factors that affect access to treatment and person-centered care. (Slide deck is in the right sidebar.)

On Thursday, November 21st, TAG hosted a training to introduce anticipated updates to the WHO guidelines for the treatment of drug-resistant TB. Putting Drug-Resistant TB Treatment Guidelines Updates in Context for Communities and Civil Society provided a breakdown of new six- and nine-month regimens and provided context for how they are likely to fit into national guidelines and TB programs in practice alongside BPaL/M. (Slide deck is in the right sidebar.)

 The next community training is Thursday, December 12th, 8:30 – 10:00 AM EDT. Drug-Resistant TB Treatment and Care in Special Populations will provide updates for communities and civil society on the latest standards of care for children and adolescents, pregnant women, and people who are incarcerated, on the move, and/or that have comorbid conditions such as HIV and hepatitis C. To join us, register here: https://us06web.zoom.us/meeting/register/tZMsfuyrqjopGNyBsOfJy2klbpnsCeBryUvE.